International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors
Author(s) -
T. Danne,
Subhash Vishal Garg,
A.L. Peters,
J.B. Buse,
C. Mathieu,
J.H. Pettus,
C.M. Alexander,
Tadej Battelino,
F.J. Ampudia-Blasco,
B.W. Bode,
B. Cariou,
K.L. Close,
P. Dandona,
Savi Dutta,
E. Ferrannini,
S. Fourlanos,
G. Grunberger,
S.R. Heller,
R.R. Henry,
M.J. Kurian,
J.A. Kushner,
T. Oron,
C.G. Parkin,
T.R. Pieber,
H.W. Rodbard,
D. Schatz,
Jay S. Skyler,
W.V. Tamborlane,
K. Yokote,
M. Phillip
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7d94-y162
Subject(s) - diabetic ketoacidosis , medicine , type 2 diabetes , canagliflozin , diabetes mellitus , ketoacidosis , endocrinology , type 1 diabetes
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom